Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05)Fuyuhiko Motoi, Michiaki Unno, Tomoo Kosuge et al.|Japanese Journal of Clinical Oncology|2018Cited by 534
Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancerMotoki Miyazawa, Hiroki Yamaue, R. Ohsawa et al.|Cancer Science|2009Cited by 117
Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architectureEva G. Álvarez, José M. C. Tubío, Jonas Demeulemeester et al.|Nature Communications|2021Cited by 56
Antitumor immune response of dendritic cells (DCs) expressing tumor‐associated antigens derived from induced pluripotent stem cells: In comparison to bone marrow‐derived DCsHiromitsu Iwamoto, Hiroki Yamaue|International Journal of Cancer|2013Cited by 22
Oncolytic virotherapy with SOCS3 enhances viral replicative potency and oncolysis for gastric cancerShuichi Matsumura, Hiroki Yamaue|Oncotarget|2021Cited by 12